0      0

210 - Urine, Bugs and Drugs!

‐ Oct 13, 2013 8:45am

APNAPN’s and RN’s can play a vital role in quickly recognizing and altering antibiotic regimens for patients that are infected with multiresistant organisms. These organisms include extended spectrum beta lactamase producers (ESBLs) and carbapenem resistant Enterobacteriaceae (CRE) and can present as urinary tract infections as well as other system infections. It is important to understand how the microlaboratory identifies these organisms and other tests that can be ordered to assist with identification. The epidemiology and risk factors for the development of colonization or infection with multiresistant organisms of the urinary tract will be discussed. Treatment patterns will be reviewed and strategies to avoid these situations will be included using case studies.

Contact hours available until 10/11/2015.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation.

Faculty, Planners, and Authors Conflict of Interest Disclosure:
Planning Commitee Disclosures:
    Lee Ann Boyd, MSN, ARNO-C, CUNP / Presenter Bureau :Warner Chilcott
    Leanne Schimke, MSN, CRNP-C CUNP/ Presenter :Amgen-Xgeva, Warner Chilott

There are no other disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
Society of Urologic Nurses and Associates is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

SUNA is a provider approved by the California Board of Registered Nursing, provider number, CEP 5556.   

  • Define minimal inhibitory concentration (MIC).
  • Discuss the mechanism for the development of ESBLs and CRE.
  • Discuss one dosing strategy to help decrease resistance.


You must be logged in and own this session in order to post comments.